Related by context. Frequent words. (Click for all words.) 61 TAXUS p value 61 annualized relapse 60 Secondary endpoints include 60 Secondary endpoints included 60 XIENCE V demonstrated 60 fraction LVEF 60 gout flares 59 QTc interval 59 cerebrovascular events 58 creatinine clearance 58 cytogenetic response 58 Montgomery Asberg Depression 58 nonfatal stroke 58 nonfatal myocardial infarction 58 events MACE 57 alteplase 57 coronary revascularization 57 XIENCE V vs. 57 infarct size 56 Thrombolysis 56 primary percutaneous coronary 56 Arch Intern Med 56 severe renal impairment 56 estimated glomerular filtration 56 clinically meaningful improvement 56 prospectively defined 56 Alzheimer Disease Assessment 56 ACR# response 56 % CI #.#-#.# [003] 56 QTc 56 discontinuations due 55 diastolic BP 55 virologic failure 55 plus dexamethasone 55 % CI #.#-#.# [007] 55 Response Evaluation Criteria 55 systemic embolism 55 composite endpoint 55 thrombotic events 55 complete cytogenetic 55 seroprotection 55 hypoglycemic events 55 platelet reactivity 55 myocardial infarction stroke 55 #mg/day [001] 55 QTc prolongation 55 fluvastatin 55 glomerular filtration rate 55 plus methotrexate 55 #:# mediaQueryString http:/static.washingtonpostZanatta 54 inflammatory lesions 54 hypomagnesemia 54 confidence interval #.#-#.# 54 Main Outcome Measures 54 thromboembolic events 54 carotid intima media 54 left ventricular dysfunction 54 Postoperative 54 Expanded Disability Status 54 CK MB 54 Secondary endpoints 54 Arch Pediatr Adolesc Med 54 Psoriasis Area 54 eplerenone 54 FOLFOX4 54 Cmax 54 prolactin levels 54 NYHA Class II 54 ADAS cog 54 mg QD 54 fatal myocardial infarction 54 paclitaxel eluting stents 54 nephrotoxicity 54 sustained virologic response 54 0 document.write 54 cardiac dysfunction 54 serum testosterone 54 venous thromboembolic events 53 cerebrovascular accident 53 P = .# 53 CD4 + cell 53 NYHA Class III 53 CI -#.# 53 irbesartan 53 cardiovascular hospitalization 53 liver transplant recipients 53 beta blocker therapy 53 tolvaptan 53 bronchodilation 53 dobutamine 53 undergoing coronary artery 53 virologic response 53 serum uric acid 53 pericardial effusion 53 patients undergoing percutaneous 53 left ventricular systolic 53 neoadjuvant 53 #.# MHz [002] 52 laboratory abnormalities 52 HSCT 52 stenoses